Filter
899
Text search:
therapeutic
use
Featured
Recommendations
115
New Publications
205
Language
Document type
No document type
479
Guidelines
156
Studies & Reports
139
Manuals
48
Strategic & Response Plan
27
Training Material
18
Fact sheets
17
Situation Updates
9
Brochures
4
Resource Platforms
2
Countries / Regions
India
42
South Africa
32
Global
29
Kenya
27
Western and Central Europe
23
Ethiopia
19
Ghana
16
Nigeria
14
Rwanda
13
Africa
13
Uganda
10
Zambia
10
Latin America and the Carribbean
10
Sierra Leone
9
Nepal
9
Tanzania
9
Malawi
9
Brazil
9
Philippines
8
Liberia
7
Congo, Democratic Republic of
7
Bangladesh
7
Eastern Europe
7
Namibia
6
Lesotho
6
South–East Asia Region
6
Russia
6
USA
5
Zimbabwe
5
Myanmar / Burma
5
South Sudan
4
Germany
4
Ukraine
4
Cameroon
3
Syria
3
Cambodia
3
Eswatini/ Swaziland
3
Middle East and North Africa
3
Guinea
2
Burkina Faso
2
Haiti
2
Pakistan
2
Iraq
2
Jordan
2
Afghanistan
2
Colombia
2
Botswana
2
Yemen
2
East and Southern Africa
2
West and Central Africa
2
Eastern Europe and Central Asia
2
Bhutan
2
Venezuela
2
Estonia
2
Iran
2
United Kingdom
2
Spain
2
Senegal
1
Mali
1
Niger
1
Somalia
1
Turkey
1
Thailand
1
Indonesia
1
Singapore
1
Mozambique
1
Sudan
1
Benin
1
Peru
1
North Macedonia
1
Hungary
1
Western Pacific Region
1
Other region
1
Paraguay
1
Asia
1
Poland
1
Albania
1
Southern Africa
1
Tajikistan
1
Lithuania
1
Uzbekistan
1
Vietnam
1
Gabon
1
Denmark
1
France
1
Maldives
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
300
Clinical Guidelines
103
Women & Child Health
56
Key Resources
52
Public Health
43
Pharmacy & Technologies
16
Capacity Building
15
Toolboxes
Mental Health
110
AMR
66
COVID-19
61
HIV
56
Pharmacy
50
TB
45
Caregiver
38
NTDs
32
NCDs
28
Disability
23
Conflict
23
Ebola & Marburg
17
Natural Hazards
13
Rapid Response
11
Refugee
11
Planetary Health
9
Social Ethics
7
Malaria
7
Zika
5
Specific Hazards
4
Polio
3
Global Health Education
3
Health Financing Toolbox
3
Cholera
2
2.0 Rapid Response
1
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt
...
The World Health Organization (WHO) recognizes the challenges countries face for maintaining their COVID-19 response while addressing competing public health challenges, conflicts, climate change and economic crises. WHO continues to support countries in adjusting COVID-19 strategies to reflect succ
...
Hypertension is the number one health related risk factor in India, with the largest contribution to burden of disease and mortality. It contributes to an estimated 1.6 million deaths, due to ischemic heart disease and stroke, out of a total of about 10 million deaths annually in India. Fifty seven
...
PMPB/INS-GUIDE/02
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi
...
PLoS Pathogens | www.plospathogens.org 1
February 2012 | Volume 8 | Issue 2 | e100246
Accessed: 03.03.2020
Introduction
Chapter A.7
Third edition
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of antimicrobials in China and I
...
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan of current narrow- spectrum antimicrobials. Althoug
...
Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compared to a placebo or controls?